Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-12-22

Clinical Trial Update: An Investigational Drug Study in Patients With Type 2 Diabetes Mellitus (0431-024) [Phase 3]

View source ↗

Summary

Phase 3 trial of an investigational drug for Type 2 diabetes mellitus completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Investigational drug 0431-024

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED | Results posted: 2009-12-22